Targeted therapy in advanced non-small cell lung cancer: current advances and future trends

Lung cancer remains the leading cause of cancer-related mortality in both men and women in the US and worldwide. Non-small cell lung cancer is the most common variety accounting for 84% of the cases. For a subset of patients with actionable mutations, targeted therapy continues to provide durable re...

Descripción completa

Detalles Bibliográficos
Autores principales: Majeed, Umair, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264982/
https://www.ncbi.nlm.nih.gov/pubmed/34238332
http://dx.doi.org/10.1186/s13045-021-01121-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264982/
https://www.ncbi.nlm.nih.gov/pubmed/34238332
http://dx.doi.org/10.1186/s13045-021-01121-2

Ejemplares similares